杏林製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2011/02/03 | 1,503 | 1,524 | 1,495 | 1,514 | +11 | +0.7% | 156,000 |
| 2011/02/02 | 1,499 | 1,518 | 1,488 | 1,503 | +17 | +1.1% | 262,000 |
| 2011/02/01 | 1,508 | 1,515 | 1,477 | 1,486 | -20 | -1.3% | 279,000 |
| 2011/01/31 | 1,495 | 1,514 | 1,495 | 1,506 | +12 | +0.8% | 269,000 |
| 2011/01/28 | 1,505 | 1,507 | 1,490 | 1,494 | -10 | -0.7% | 225,000 |
| 2011/01/27 | 1,488 | 1,520 | 1,488 | 1,504 | +13 | +0.9% | 353,000 |
| 2011/01/26 | 1,495 | 1,499 | 1,483 | 1,491 | -8 | -0.5% | 155,000 |
| 2011/01/25 | 1,493 | 1,508 | 1,479 | 1,499 | +12 | +0.8% | 276,000 |
| 2011/01/24 | 1,483 | 1,487 | 1,469 | 1,487 | +22 | +1.5% | 116,000 |
| 2011/01/21 | 1,471 | 1,531 | 1,463 | 1,465 | +12 | +0.8% | 595,000 |
| 2011/01/20 | 1,450 | 1,460 | 1,440 | 1,453 | +3 | +0.2% | 260,000 |
| 2011/01/19 | 1,467 | 1,475 | 1,445 | 1,450 | -16 | -1.1% | 266,000 |
| 2011/01/18 | 1,465 | 1,475 | 1,461 | 1,466 | +2 | +0.1% | 163,000 |
| 2011/01/17 | 1,485 | 1,489 | 1,455 | 1,464 | -28 | -1.9% | 356,000 |
| 2011/01/14 | 1,443 | 1,505 | 1,442 | 1,492 | +44 | +3% | 638,000 |
| 2011/01/13 | 1,431 | 1,455 | 1,425 | 1,448 | +14 | +1% | 283,000 |
| 2011/01/12 | 1,437 | 1,440 | 1,421 | 1,434 | +1 | +0.1% | 260,000 |
| 2011/01/11 | 1,407 | 1,439 | 1,405 | 1,433 | +21 | +1.5% | 336,000 |
| 2011/01/07 | 1,420 | 1,421 | 1,400 | 1,412 | -9 | -0.6% | 289,000 |
| 2011/01/06 | 1,429 | 1,429 | 1,418 | 1,421 | -9 | -0.6% | 152,000 |
| 2011/01/05 | 1,417 | 1,430 | 1,416 | 1,430 | +13 | +0.9% | 178,000 |
| 2011/01/04 | 1,422 | 1,429 | 1,401 | 1,417 | -4 | -0.3% | 295,000 |
| 2010/12/30 | 1,414 | 1,444 | 1,414 | 1,421 | ±0 | ±0% | 180,000 |
| 2010/12/29 | 1,407 | 1,425 | 1,407 | 1,421 | +4 | +0.3% | 122,000 |
| 2010/12/28 | 1,395 | 1,422 | 1,395 | 1,417 | +10 | +0.7% | 106,000 |
| 2010/12/27 | 1,402 | 1,415 | 1,394 | 1,407 | -7 | -0.5% | 163,000 |
| 2010/12/24 | 1,420 | 1,424 | 1,410 | 1,414 | -15 | -1% | 291,000 |
| 2010/12/22 | 1,435 | 1,440 | 1,426 | 1,429 | -6 | -0.4% | 190,000 |
| 2010/12/21 | 1,416 | 1,441 | 1,416 | 1,435 | +10 | +0.7% | 190,000 |
| 2010/12/20 | 1,436 | 1,436 | 1,415 | 1,425 | -14 | -1% | 193,000 |
| 2010/12/17 | 1,427 | 1,442 | 1,427 | 1,439 | +15 | +1.1% | 277,000 |
| 2010/12/16 | 1,407 | 1,432 | 1,407 | 1,424 | +3 | +0.2% | 278,000 |
| 2010/12/15 | 1,386 | 1,421 | 1,386 | 1,421 | +27 | +1.9% | 402,000 |
| 2010/12/14 | 1,386 | 1,402 | 1,385 | 1,394 | +8 | +0.6% | 190,000 |
| 2010/12/13 | 1,369 | 1,388 | 1,362 | 1,386 | +13 | +0.9% | 251,000 |
| 2010/12/10 | 1,369 | 1,381 | 1,362 | 1,373 | -6 | -0.4% | 309,000 |
| 2010/12/09 | 1,384 | 1,388 | 1,370 | 1,379 | +10 | +0.7% | 359,000 |
| 2010/12/08 | 1,372 | 1,396 | 1,357 | 1,369 | -37 | -2.6% | 649,000 |
| 2010/12/07 | 1,382 | 1,426 | 1,377 | 1,406 | +5 | +0.4% | 445,000 |
| 2010/12/06 | 1,400 | 1,432 | 1,394 | 1,401 | -9 | -0.6% | 552,000 |
| 2010/12/03 | 1,380 | 1,453 | 1,377 | 1,410 | +60 | +4.4% | 2,119,000 |
| 2010/12/02 | 1,365 | 1,373 | 1,345 | 1,350 | -8 | -0.6% | 322,000 |
| 2010/12/01 | 1,345 | 1,369 | 1,337 | 1,358 | +23 | +1.7% | 562,000 |
| 2010/11/30 | 1,340 | 1,350 | 1,331 | 1,335 | +3 | +0.2% | 383,000 |
| 2010/11/29 | 1,313 | 1,338 | 1,313 | 1,332 | +12 | +0.9% | 189,000 |
| 2010/11/26 | 1,318 | 1,330 | 1,315 | 1,320 | -5 | -0.4% | 306,000 |
| 2010/11/25 | 1,345 | 1,345 | 1,317 | 1,325 | -2 | -0.2% | 340,000 |
| 2010/11/24 | 1,320 | 1,335 | 1,318 | 1,327 | -2 | -0.2% | 251,000 |
| 2010/11/22 | 1,328 | 1,333 | 1,315 | 1,329 | +10 | +0.8% | 248,000 |
| 2010/11/19 | 1,318 | 1,326 | 1,299 | 1,319 | -4 | -0.3% | 253,000 |
3251～
3300
件表示中 / 3457件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 杏林製薬 | 171,200円 | +3.2% | +4.5% | 3.04% | 19.67倍 | 0.75倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 持田薬 | 304,000円 | +3.0% | +27.5% | 2.63% | 19.25倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 鳥居薬 | 386,000円 | +7.3% | +16.8% | 3.11% | 23.09倍 | 0.90倍 |
|
ＪＴ傘下。自社製品の腎・透析、アレルゲン等の開発強化。柱の抗ＨＩＶ薬の販売権喪失が直撃 |
| ジーエヌアイ | 235,600円 | +52.1% | +23.3% | 0.00% | 16.65倍 | 3.47倍 |
|
創薬ベンチャー。米国で人工骨も。中国の特発性肺線維症薬で高シェア、米中に研究開発機能 |
| ゼリア新薬 | 200,800円 | +9.6% | +17.5% | 2.29% | 11.34倍 | 1.11倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
